FDA Inspection 1255308 — Vesta Pharmaceuticals
The FDA completed an inspection of Vesta Pharmaceuticals on Oct 31, 2024 in Indianapolis, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Veterinary.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 31, 2024
- Fiscal Year
- 2025
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Indianapolis, IN (United States)